Aimovig 140 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FUPMS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,541
Award facts
- Contract value 100% obligated
- $10,541.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,541.19 to AmerisourceBergen Drug Corp for the supply of Aimovig 140 mg/ml autoinjectors. The contract, which is a non-set-aside, firm fixed-price delivery order, was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare operations globally.
Aimovig is a monoclonal antibody treatment for migraine prevention, representing a specialized pharmaceutical product within the broader portfolio of neurological medications that AmerisourceBergen supplies through its federal contracts. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to meet DLA's medical procurement requirements through competitive contracting, with its federal contract awards encompassing a wide range of therapeutic domains from specialty medications to medical devices. The company's DLA contract serves military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities, positioning it as a critical vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FUPMS?
SPE2DB25FUPMS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FUPMS worth?
The government has obligated $10,541 on SPE2DB25FUPMS.
Is contract SPE2DB25FUPMS an order under another contract?
Yes. SPE2DB25FUPMS is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUPMS competed?
The extent of competition for SPE2DB25FUPMS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award